The weekly litigation news digest is live. Subscribe now

Patent Oppositions in form specific drugs industry

Explore the competitive field of form specific drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in form specific drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the form specific drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the form specific drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jan 22, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Salt Of A Pyrimido[6,1-A]Isoquinolin-4-One CompoundVERONA PHARMADec 19, 2025KELTIE
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 19, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 19, 2025HAMM & WITTKOPP
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 18, 2025KARO
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025ABEL & IMRAY
Salt Of A Pyrimido[6,1-A]Isoquinolin-4-One CompoundVERONA PHARMADec 17, 2025BARDEHLE PAGENBERG
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 17, 2025BRAND MURRAY FULLER
Tablets Comprising Eltrombopag OlamineNOVARTISDec 16, 2025DEVA HOLDING
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 15, 2025STRAWMAN
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 8, 2025TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB

To stay ahead in the competitive form specific drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the form specific drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jan 22, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Nov 13, 2019Apixaban FormulationsPFIZER12
Aug 18, 2021Formulations Of EnzalutamideASTELLAS PHARMA12
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 5, 2018Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED10
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10